Skip to content
Clinical Trials – home
Agencja Badań Medycznych
Sponsor

Agencja Badań Medycznych

Poland ul. Chmielna 69, 00-801 Warsaw, Poland

About the sponsor

The sponsor funds research in acute coronary syndrome, myocardial infarction, heart failure, arrhythmogenic cardiomyopathy, and antiplatelet therapy, with additional focus on transcatheter edge-to-edge repair and left atrial appendage closure. Its portfolio also includes prevention and treatment of anthracycline-related cardiotoxicity and cancer therapeutics-related cardiac dysfunction.

  • Acute coronary syndrome and post-infarction care
  • Heart failure and cardiac dysfunction
  • Cardiotoxicity in cancer treatment
  • Antithrombotic and antiplatelet strategies

Research activity also covers iron deficiency in cardiac disease and fibrotic and remodeling pathways in structural heart conditions.

About Specializations

Agencja Badań Medycznych runs clinical trials in conditions such as Hypertension, Atrial fibrillation, Cardiac failure, Cardiomyopathy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

28 clinical trials

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Keto-Leucine Calcium
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tianeptine Sodium
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Agencja Badań Medycznych

Crohn's disease

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Agencja Badań Medycznych
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Agencja Badań Medycznych

Lichen sclerosus+1

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Mometasone Furoate
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Amlodipine
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Allopurinol
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Metformin Hydrochloride
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Metformin Hydrochloride
  • Sponsor:Agencja Badań Medycznych

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).